Canada Pension Plan Investment Board
TERN

Canada Pension Plan Investment Board’s Terns Pharmaceuticals TERN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Sell
22,600
-122,200
-84% -$5.02M ﹤0.01% 982
2025
Q4 		$5.85M Buy
144,800
+143,400
+10,243% +$3.31M ﹤0.01% 749
2025
Q3 		$10.5K Sell
1,400
-10,900
-89% -$69.6K ﹤0.01% 1322
2025
Q2 		$45.9K Buy
+12,300
New +$38.4K ﹤0.01% 1262

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Canada Pension Plan Investment Board's TERN Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Terns Pharmaceuticals (TERN) stake by 84% in Q1 2026, selling an estimated $5.02M and leaving 22,600 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Canada Pension Plan Investment Board first reported a position in TERN in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.85M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Canada Pension Plan Investment Board held 22,600 shares of Terns Pharmaceuticals worth $1.19M as of Q1 2026.
  • Canada Pension Plan Investment Board sold 122,200 Terns Pharmaceuticals shares in Q1 2026, an estimated $5.02M.
  • Terns Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #982 holding.
  • Canada Pension Plan Investment Board first reported a position in Terns Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Terns Pharmaceuticals position peaked at $5.85M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.